Brickell Biotech (BBI) Stock Analysis
NASDAQHealthcareBiotechnology
Track BBI in your portfolio for free · Portfolio tracker
What Brickell Biotech does
Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.
Key metrics
ETFs linked to BBI
Broad-market and Healthcare sector ETFs an investor holding Brickell Biotech is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how BBI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BBI in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Brickell Biotech?
- Brickell Biotech trades under the ticker BBI on NASDAQ.
- Which exchange is BBI listed on?
- BBI is listed on NASDAQ.
- What sector does Brickell Biotech operate in?
- Brickell Biotech is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze BBI in a portfolio?
- PortView shows BBI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.